The next confirmation statement is due 15 Apr 2027 based on current public-register data.
Public company register page
NOVARTIS PHARMACEUTICALS UK LIMITED
Companies House number 00119006. This page summarizes the public-register confirmation statement deadline and due date for this company, alongside officers, PSCs, and recent filing history from Companies House.
3 active officers currently exposed on the public register.
1 active people with significant control currently exposed on the public register.
Confirmation statement made on 2026-04-01 with no updates on 2 Apr 2026
Entity Watch briefing
NOVARTIS PHARMACEUTICALS UK LIMITED is currently listed as active and recorded as a ltd on the public register. The next confirmation statement is due 15 Apr 2027, which is the next obvious register deadline to watch. The freshest filing signal is confirmation statement made on 2026-04-01 with no updates on 2 Apr 2026.
The next confirmation statement is due 15 Apr 2027, 367 days from today, so this is the next obvious compliance checkpoint for the company record.
Only one active PSC is currently exposed on the public register, which points to a concentrated control profile rather than a broad shareholder picture.
The most recent filing is a confirmation statement update: Confirmation statement made on 2026-04-01 with no updates on 2 Apr 2026. That usually means the company has refreshed its core register details rather than filed an operational or distress event.
This company has been on the public register since 8 Dec 1911 - roughly 114 years - which helps separate an established record from a newly formed one.
Quick answers about NOVARTIS PHARMACEUTICALS UK LIMITED
These answer the exact register questions people usually search first.
When is the next confirmation statement due for NOVARTIS PHARMACEUTICALS UK LIMITED?
The next confirmation statement due date currently shown on the public record is 15 Apr 2027.
Is NOVARTIS PHARMACEUTICALS UK LIMITED overdue?
Entity Watch currently reads this company as no immediate confirmation-statement pressure. The next confirmation statement is due 15 Apr 2027 based on current public-register data.
Who are the active officers of NOVARTIS PHARMACEUTICALS UK LIMITED?
The public register currently shows 3 active officers: CULLEN, Richard Samuel, GUPTA, Sandeep, KAHLSTROEM, Johan Mikael Olof.
Who are the PSCs of NOVARTIS PHARMACEUTICALS UK LIMITED?
The public register currently shows 1 active PSC: Novartis Uk Limited.
What was the latest filing for NOVARTIS PHARMACEUTICALS UK LIMITED?
The latest filing currently shown is Confirmation statement made on 2026-04-01 with no updates dated 2 Apr 2026 with filing code CS01.
What CS01 meansWhat changed recently at NOVARTIS PHARMACEUTICALS UK LIMITED?
NOVARTIS PHARMACEUTICALS UK LIMITED is currently listed as active and recorded as a ltd on the public register. The next confirmation statement is due 15 Apr 2027, which is the next obvious register deadline to watch. The freshest filing signal is confirmation statement made on 2026-04-01 with no updates on 2 Apr 2026.
Company facts
2nd Floor, The Westworks Building White City Place, 195 Wood Lane, London, W12 7FQ, United Kingdom
8 Dec 1911
15 Apr 2027
1 Apr 2027
Officers
Current public-register officers for this company.
Secretary
Appointed 1 Jan 2026
Director
Appointed 12 May 2025
Director
Appointed 1 Nov 2024
Recent filing history
Latest filing events exposed through the Companies House filing-history API.
Confirmation statement made on 2026-04-01 with no updates2 Apr 2026
Form CS01. Filed on 2026-04-02.
Appointment of Mr Richard Samuel Cullen as a secretary on 2026-01-015 Jan 2026
Form AP03. Filed on 2026-01-05.
Termination of appointment of Timothy William Robinson as a secretary on 2026-01-015 Jan 2026
Form TM02. Filed on 2026-01-05.
Full accounts made up to 2024-12-313 Oct 2025
Form AA. Filed on 2025-10-03.
Appointment of Mr Sandeep Gupta as a director on 2025-05-1213 May 2025
Form AP01. Filed on 2025-05-13.
Termination of appointment of Jason Mark Brooks as a director on 2025-04-0817 Apr 2025
Form TM01. Filed on 2025-04-17.
Confirmation statement made on 2025-04-01 with no updates2 Apr 2025
Form CS01. Filed on 2025-04-02.
Director's details changed for Mr Johan Mikael Olof Kahlstroem on 2025-01-0914 Jan 2025
Form CH01. Filed on 2025-01-14.
Appointment of Mr Johan Mikael Olof Kahlstroem as a director on 2024-11-015 Nov 2024
Form AP01. Filed on 2024-11-05.
Termination of appointment of Marie-Andree Renee Gamache as a director on 2024-10-314 Nov 2024
Form TM01. Filed on 2024-11-04.
Full accounts made up to 2023-12-316 Aug 2024
Form AA. Filed on 2024-08-06.
Confirmation statement made on 2024-04-01 with no updates3 Apr 2024
Form CS01. Filed on 2024-04-03.